Evidence map›Paper›PMID 37843670›Full record

ArticleEJNMMI radiopharmacy and chemistry2023

Fully automated radiosynthesis of [

Adam J Rosenberg, Yiu-Yin Cheung, Fei Liu, Carina Sollert, Todd E Peterson, Jonathan A Kropski

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Production and Quality Control of [Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  2. [Current radiopharmaceuticals · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adam J RosenbergVanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. adam.j.rosenberg@vumc.org.ORCID http://orcid.org/0000-0003-2459-7043
Yiu-Yin CheungVanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Fei LiuVanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Carina SollertGE HealthCare, Uppsala, Sweden.
Todd E PetersonVanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Jonathan A KropskiDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.

Funding

Boehringer Ingelheim IIS_2020_00001912
6 · The paper itself

Abstract

backgroundRadiopharmaceuticals capable of targeting the fibroblast activation protein have become widely utilized in the research realm as well as show great promise to be commercialized; with [

resultsA fully-automated manufacturing process for [ STANDARDS:

conclusionsThe automated radiosynthesis on the GE FASTlab 2 module purifies the cyclotron output into [

Indexed as

AutomationCyclotronFAPIGallium-68GMP complianceRadiochemistryRadiolabelingRadiopharmaceuticals

Identifiers

PMID37843670
PMCPMC10579206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.